HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 73-84 of 4,505
Device study icon
Not Yet RecruitingACTRN12626001211358

Feasibility and acceptability of an intranasal blank sol-gel administration in healthy adults and individuals diagnosed with schizophrenia.

Official study title

An open label study to evaluate the tolerability of 14-day self-administration of intranasal Sol-Gel in healthy adults and individuals with schizophrenia.

This study isn't recruiting yet.

In Woolloongabba
SchizophreniaInterventional studyAges 18–64
Countries
Australia
Sponsor
Metro South Hospital land Health Services
Behavioral study icon
Not Yet RecruitingACTRN12619000723189

Lifestyle Intervention: Study for people with schizophrenia treated with either clozapine or another antipsychotic medication

Official study title

Pilot study to evaluate the effect of a lifestyle intervention: on quality of physical and mental health in people with schizophrenia treated with either clozapine or another antipsychotic medication who are overweight/obese

This study isn't recruiting yet.

In Australia
SchizophreniaInterventional studyAges 18–65
Countries
Australia
Sponsor
Hunter New England Mental Health Local health District
Drug study icon
Not Yet RecruitingACTRN12626000530325

Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)

Official study title

Schizophrenia Platform for Improving Recovery with Integrated Trials (SPIRIT) – Appendix C: Domain-Specific Appendix GLP-1RA - Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)

This study isn't recruiting yet.

In Australia
SchizophreniaInterventional studyAges 18–64
Countries
Australia
Sponsor
University of Queensland
Drug study icon
Not Yet RecruitingACTRN12609000184279

Tailoring Adjunct Glycine Therapy in Schizophrenia

Official study title

Tailoring Adjunct Glycine Therapy to Improve Cognitive Function and Clinical Symptoms in Schizophrenia

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaInterventional studyAges 18–45
Countries
Sponsor
Alfred Hospital
Drug study icon
Not Yet RecruitingACTRN12625000327482

INTENSIFY Trial: The Effect of a Six-Week Intensified Pharmacological Treatment (Third-Line Medication) for schizophrenia

Official study title

Randomised, Controlled Trial to Investigate the Effect of a six-week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Participants Who Had a First-time Treatment Failure on Their First-line Treatment for -Schizophrenia Cohort.

This study isn't recruiting yet.

In Australia
SchizophreniaInterventional studyAges 18–65
Countries
Australia
Sponsor
Lyell McEwin Hospital
Behavioral study icon
RecruitingNCT06071858

Enhanced Coordinated Specialty Care for Early Psychosis

Official study title

Cluster Randomized Trial of Enhanced Coordinated Specialty Care (CSC 2.0) for Early Psychosis

Multiple locations, including Belmont
Schizophrenia, BipolarityBehavioural study
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Drug study icon
RecruitingACTRN12621000349842

Cannabidiol for At Risk for psychosis Youth

Official study title

The effect of Cannabidiol on positive psychotic symptoms in At Risk for psychosis Youth: A randomised controlled trial

In Australia
SchizophreniaInterventional studyAges 12–25
Countries
Australia
Sponsor
Orygen
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.